Measuring changes in -cell mass in vivo during progression of diabetes mellitus is important for understanding the pathogenesis, facilitating early diagnosis, and developing novel therapeutics for this disease. However, a non-invasive method has not been developed. 
Synthesis and evaluation of 18 
Introduction
The International Diabetes Federation has reported that the total number of people with diabetes mellitus will rise from 285 million in 2009 to 435 million in 2030.
There are two major types of diabetes mellitus: type-1 diabetes (T1D) and type-2 diabetes (T2D) [1] . T1D is characterized by selective destruction of -cells by the autoimmune reaction, and pancreatic-cell mass (BCM) in T1D is already lost at disease onset. T2D is characterized by the decreased ability to secrete insulin and increased insulin resistance, it also has been reported that BCM in T2D is decreased significantly [2] [3] [4] [5] . Recently, incretin-related drugs were reported to have proliferative and anti-apoptotic effects on pancreatic -cells in in vitro or rodent experiments [6] [7] [8] .
However, to date, non-invasive quantification of BCM has not been possible, so how and when a decrease in BCM begins and whether incretin-related drugs preserve BCM in humans is not known. Therefore, a non-invasive method for BCM measurement is required urgently for understanding the pathogenesis, facilitating early diagnosis, and developing novel therapeutics for diabetes.
Sulfonylurea (SU) agents are insulin secretagogues, and are used widely in T2D treatment. They close the adenosine triphosphate-sensitive potassium ion channel (K ATP channel) in the pancreatic -cell membrane, thereby depolarizing the cell and triggering insulin secretion [9] . The K ATP channel is an octameric complex of two protein subunits, an inwardly rectifying K + (Kir6.x) ion channel and a sulfonylurea receptor (SUR), which is the target for SU agents [9, 10] . The pancreatic -cell K ATP channel is composed of Kir6.2 and SUR1 subunits [11] . Other K ATP channels comprise Kir6.2 and SUR2A (heart muscle and skeletal muscle), Kir6.2 and SUR2B (smooth muscle), and Kir6.1 and SUR2B (vascular smooth muscle) [9] . In recent years, SUR2B expression in human liver tissue has been described [12] .
Several radiolabeled tracers based on the core structure of SU agents have been developed as imaging probes for SUR1 ( Figure 1 ) in recent years [13] [14] [15] [16] [17] [18] . However, these imaging probes are not available because of low uptake in pancreatic tissue and high uptake in liver tissue located close to the pancreas. Promising candidates for pancreatic -cell imaging tracers based on SU agents need to have relatively low lipophilicity and have high affinity for SUR1. In this context, mitiglinide is a promising (Figure 2 ). 
Results and discussion

Chemistry
The synthesis of mitiglinide derivatives containing fluorine (o-, m-and p-FMIT) is shown in Scheme 1. The succinic acid derivatives 2a-c were prepared, using a method based on the synthetic strategy reported by Kamijo et al. [20] , by cross-aldol condensation of the benzaldehydes 1a, b, and c (which have a benzyloxy group at the o-, m-, and p-position, respectively) with dimethyl succinate in the presence of potassium hydroxide, followed by hydrolysis of the ester. Acids 2a-c were treated with acetic anhydride in dichloromethane to afford the cyclic acid anhydride derivatives, followed by amidation with 3a,4,7,7a-tetrahydroisoindoline (3) and successive esterification to afford the amides 4a-c. Catalytic hydrogenation of 4a-c gave the phenols 5a-c. Finally, 5a-c were alkylated with 2-fluoroethyl tosylate in the presence of cesium carbonate in DMF, followed by saponification with aqueous sodium hydroxide in 1,4-dioxane to give (±)-FMIT. Optical resolution using HPLC with a chiral column gave enantiomerically pure (+)-FMIT and (−)-FMIT (o-, m-and p-, respectively).
In vitro Binding Assays
The FMITs were evaluated using dispersed islet cells from ddY mice pancreas. The results of these assays are summarized in Table 1 . 
Stereochemistry
The absolute configuration of (+)-o-FMIT and (−)-o-FMIT was determined by 1 H-NMR spectra using corresponding -methoxy--(trifluoromethyl)phenylacetic acid (MTPA) esters with Eu(fod) 3 [21] [22] [23] [24] .
(+)-o-FMIT and (−)-o-FMIT were transformed
into corresponding diastereomeric esters 6 by reduction of the carboxyl group and esterification according to the method of Dale et al. [25, 26] . The magnitude of the lanthanide-induced shift (LIS) by Eu(fod) 3 for the methoxyl group of 6 in 1 H-NMR indicated that the configuration of (+)-o-FMIT was S and that of (−)-o-FMIT was R (Scheme 2). The result of the binding affinity for pancreatic -cell SUR1 of each enantiomer suggested that the S-configuration of o-FMIT (which has the same absolute configuration as mitiglinide) was important for binding affinity. 
Biodistribution Studies
The tissue time-course distributions of (+) pancreas-to-kidney (P/K), and pancreas-to-blood (P/B) ratios at different time points are shown in Figure 6 . The P/L ratio was ≤0.57 at 60 min, the P/K ratio was ≤0.81 at 120 min, and the P/B ratio was ≤0.64 at 60 min.
It is considered that the hepatic clearance of (+)-(S)-o-[ 18 F]FMIT is relatively rapid and that the P/L is high when compared with other radiolabeled compounds based on SU agents [14] [15] [16] . 
Ex vivo Autoradiography
To further characterize the potential of (+) Figure 7 ). 
Conclusions
We synthesized a novel series of mitiglinide derivatives In addition, we determined the absolute configuration of each enantiomer of o-FMIT by 1 H-NMR spectra using MTPA esters with Eu(fod) 3 , which showed that the exact configuration at the 2-position of FMITs must be especially important to the affinity for SUR1.
We synthesized ( 
Animal experiments
Six-week-old male ddY mice were obtained from Japan SLC (Kyoto, Japan).
Animal studies were conducted in accordance with institutional guidelines. 
2-(2-Benzyloxybenzylidene)succinic acid (2a)
The reaction was carried out with o-benzyloxybenzaldehyde (1a) (5.00 g, 23.6 mmol) in dimethyl sulfoxide (24 mL) to afford 2a (2.98 g, 40% 
2-(3-Benzyloxybenzylidene)succinic acid (2b)
The reaction was carried out with m-benzyloxybenzaldehyde (1b) (7. 
2-(4-Benzyloxybenzylidene)succinic acid (2c)
The reaction was undertaken with p-benzyloxybenzaldehyde (1c) (5.00 g, 23.5 mmol) in dimethyl sulfoxide (30 mL) to afford 2c (2.80 g, 38% 
Methyl 2-(3-benzyloxybenzylidene)-4-oxo-4-(cis-3a,4,7,7a-tetrahydro-isoindolin-2-yl) butanoate (4b)
The reaction was undertaken with 2b (3.00 g, 9.61 mmol) to afford 4b (1.85 g, 45% 
Methyl 2-(4-benzyloxybenzylidene)-4-oxo-4-(cis-3a,4,7,7a-tetrahydro-isoindolin-2-yl) butanoate (4c)
The reaction was carried out with 2c (3.00 g, 9.61 mmol) to afford 4c (2.89 g, 70% 
Procedure for the preparation of FMIT
Step 1: Cesium carbonate (1.4 eq) was added to a solution of 5a-c and 2-fluoroethyl tosylate (1.5 eq) in dimethyl formamide, and the mixture stirred at 60 °C.
After chilling the reaction mixture to room temperature, the mixture was poured into water and extracted with diethyl ether. The organic layer was washed with a small amount of water, dried over magnesium sulfate, and evaporated under vacuum. The residue was purified using silica gel column chromatography (n-hexane/ethyl acetate = 1/1) to afford the methyl ester.
Step 2: An aqueous solution of sodium hydroxide (2 M) was added to a solution of the methyl ester in 1,4-dioxane, and the mixture stirred at 50 °C. After chilling the reaction mixture to room temperature, it was acidified with 1 N hydrochloric acid and extracted with ethyl acetate. The organic layer was washed with brine, dried over magnesium sulfate, and evaporated under vacuum. The residue was purified using silica gel column chromatography (chloroform/methanol = 9/1) to afford FMIT.
2-(2-Fluoroethyloxybenzyl)-4-(cis-3a,4,5,6,7,7a-hexahydro-isoindolin-2-yl)-4-oxobu tanoicacid (o-FMIT)
The step-1 reaction was carried out with 5a (386.9 mg, 1.12 mmol) in dimethyl 
2-(3-Fluoroethyloxybenzyl)-4-(cis-3a,4,5,6,7,7a-hexahydro-isoindolin-2-yl)-4-oxobu tanoic acid (m-FMIT)
The step-1 reaction was carried out with 5b (65.6 mg, 0.19 mmol) in dimethyl formamide (2 mL) for 13 hours to afford the corresponding methyl ester (56.1 mg, 76%). 
2-(4-Fluoroethyloxybenzyl)-4-(cis-3a,4,5,6,7,7a-hexahydro-isoindolin-2-yl)-4-oxobu tanoic acid (p-FMIT)
The step-1 reaction was undertaken with 5c (57.6 mg, 0.17 mmol) in dimethyl formamide (2 mL) for 21 hours to afford the corresponding methyl ester compound 
Procedure for the preparation of MTPA esters (S,R)-6 and (R,R)-6.
Isobutyl chloroformate (2.0 eq) was added to a solution of triethylamine (2. 
2-yl)-4-oxobutanoate (7)
Cesium carbonate (1.16 g, 3.6 mmol) was added to a solution of 5a (560 mg, 1.6 mmol) and 2-bromoethyl p-toluenesulfonate (1.09 g, 3.9 mmol) in dimethyl formamide (8 mL), and the mixture stirred at 40 °C over one weekend. After chilling the reaction mixture to room temperature it was poured into water and extracted with ethyl acetate. The organic layer was washed with water and brine, dried over magnesium sulfate, and evaporated under vacuum. The residue was purified using silica gel column chromatography (n-hexane/ethyl acetate = 4/1 to 1/1) to afford 7 (440 mg, 60% 
In vitro Binding Assays
The displacement effect of the mitiglinide derivatives on SUR1 binding was assessed using dispersed islet cells as described previously [27] . Pancreatic islets were isolated from male ddY mice by a collagenase digestion method [14] . with a radiochemical yield of 18% and 13% (overall decay corrected). The radiochemical purity of these radiotracers was >98% after purification by high-performance liquid chromatography (HPLC) and their specific activity estimated to be ≈100 GBq/μmol.
Biodistribution Studies
Biodistribution studies of (+) (thickness, 10 m), placed on a glass slide, and covered with a glass cover. The radioactivity of a pancreatic section on a glass slide was determined using an imaging analyzer (BAS5000, Fujifilm Photo Film, Tokyo, Japan) (18-hours exposure).
Ex vivo Autoradiography Experiments
Immunohistochemistry
Serial sections of pancreas prepared for autoradiography were fixed with 4% paraformaldehyde in 0.1 M phosphate buffer for 1 hour, then permeabilized and blocked with 0.5% Triton X-100 in PBS containing 1.5% goat serum for 1 hour at room temperature. Specimens were incubated with rabbit anti-insulin (1:50 dilution; Santa
Cruz Biotechnology, Santa Cruz, CA, USA) as a primary antibody overnight at 4 °C.
After rinsing with PBS, specimens were incubated with Alexa Fluor 488-labeled goat anti-rabbit IgG (1:200; Molecular Probes, Eugene, OR, USA) as a secondary antibody for 1 hour at room temperature. Fluorescence signals were acquired through a fluorescence microscope (BZ-9000, KEYENCE, Osaka, Japan).
Statistical Analyses
Data are the mean ± SD. The statistical significance of differences was evaluated using the Tukey-Kramer test. P < 0.05 was considered significant. Values are %ID/g (mean ± S.D.) for 5 animals at each interval.
